CN108478855A - A kind of bleeding-stopping dressing - Google Patents

A kind of bleeding-stopping dressing Download PDF

Info

Publication number
CN108478855A
CN108478855A CN201810460000.8A CN201810460000A CN108478855A CN 108478855 A CN108478855 A CN 108478855A CN 201810460000 A CN201810460000 A CN 201810460000A CN 108478855 A CN108478855 A CN 108478855A
Authority
CN
China
Prior art keywords
bleeding
parts
dressing
stopping dressing
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810460000.8A
Other languages
Chinese (zh)
Inventor
邵玉芹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810460000.8A priority Critical patent/CN108478855A/en
Publication of CN108478855A publication Critical patent/CN108478855A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Abstract

The present invention provides a kind of bleeding-stopping dressings, by absorbent gelling crosslinked polymer sodium carboxymethylcellulose wound blood is absorbed in wound, sticky spawn can be formed, styptic powder sticking in wound is increased, chitosan not only plays the role of sterilization, also has the function of enhancing gel-forming, and the addition for passing through calcium chloride, the hemostatic function of composition is further enhanced, the composition manufacturing cost is low, and haemostatic effect is excellent.

Description

A kind of bleeding-stopping dressing
Technical field
This application involves field of pharmaceutical preparations more particularly to a kind of bleeding-stopping dressing fields.
Background technology
It is one of dead most important reason of the war wound wounded to lose blood, and is generally divided into internal bleeding and external bleeding, goes out in vivo Blood is mostly due to Viscera rupture, and external bleeding is substantially damaged due to arteriovenous, and dressing is as hemostatic material, refers to lid On wound, there is the covering of protective effect, control bleeding can be assisted, prevent from infecting and absorbing secretion, bleeding-stopping dressing pair It has great significance in timely hemostasis.
Traditional hemostatic material is generally divided into following several classes：Traditional cotton fabric material, biological medical polymer material, people The dressing of work fibrin, minerals dressing, liquid type dressing, metal class dressing, wherein traditional cotton goods dressing is as hemostatic material Material, refers to the covering for covering on wound, having protective effect, can assist control bleeding, prevent from infecting and absorbing secretion, only Blood dressing has great significance for stopping blooding in time, but only plays physical protection to the surface of a wound, without coagulation factor, and is easy It is adhered the surface of a wound；High molecular material is generally divided into natural polymer and synthesis high molecular material, using this material to local stimulation It is smaller, but haemostatic effect is often poor；The haemostatic effect of artificial fiber albumen dressing is excellent, but manufacturing cost is higher；Mineral Matter dressing, liquid type dressing, the dressing of metal class, which have the hemostasis of internal wound, applies upper limitation.
Invention content
In order to solve the problems in the existing technology, the present invention provides a kind of bleeding-stopping dressing, which is powdery group Close object, characterized in that the polymer containing water absorption and swelling, fungicide, rush blood coagulation substance in composition.
Further, the polymer of water absorption and swelling is croscarmellose sodium；
Further, fungicide is selected from chitosan；
Further, promote blood coagulation substance and be selected from calcium chloride, fibrinogen, vitamin K, collagen, fibronectin, blood coagulation One or more of factor combines；
Further, preservative, filler are contained in composition；
Further, the one kind or several of preservative in methyl hydroxybenzoate, ethyl hydroxy benzoate, sodium benzoate, dimethyl fumarate Kind combination；
Further, filler is selected from talcum powder, starch, lactose, calcium carbonate, dextrin, microcrystalline cellulose；
Invention further provides a kind of bleeding-stopping dressings, it is characterised in that：The dressing is powder composition, in composition Contain following components by weight percent substance：20-50 parts of croscarmellose sodium, promotees 1 part of blood coagulation substance at 15-45 parts of fungicide.
Further, following parts by weight of component substance is contained in composition：20-50 parts of croscarmellose sodium, sterilization 15-45 parts of agent promotees 1 part of blood coagulation substance, 2 parts of methyl hydroxybenzoate, 16 parts of talcum powder, 16 parts of lactose；
Further, change dressing and contain following parts by weight of component：50 parts of croscarmellose sodium, 15 parts of chitosan, chlorine Change 1 part of calcium, 2 parts of methyl hydroxybenzoate, 16 parts of talcum powder, 16 parts of lactose.
Invention further provides a kind of preparation methods of bleeding-stopping dressing, it is characterised in that：By cross-linked carboxymethyl fiber Plain sodium, calcium chloride, lactose are added in suitable quantity of water, and heating makes to be completely dissolved, and obtain solution A, and methyl hydroxybenzoate, which is dissolved in ethyl alcohol, obtains solution Solution B is slowly added into solution A by B under agitation, continues to stir, and chitosan is added, and high speed shear 2 hours obtains Mixed liquor C is freeze-dried to obtain uniformly powdered dressing by mixed liquor C.
The beneficial effects of the invention are as follows：
The present invention absorbs wound blood by absorbent gelling crosslinked polymer sodium carboxymethylcellulose in wound, can be formed Sticky spawn increases styptic powder sticking in wound, and chitosan not only plays the role of sterilization, Have the function of enhancing gel-forming, and by the addition of calcium chloride, further enhances the hemostatic function of composition, the combination Object manufacturing cost is low, and haemostatic effect is excellent.
Specific implementation mode
With reference to embodiment, the present invention is described in further detail, but protection scope of the present invention is not limited to this.
Embodiment 1
Croscarmellose sodium 50%, chitosan 15%, calcium chloride 1%, methyl hydroxybenzoate 2%, talcum powder 16%, breast Sugar 16%；
Preparation method：Croscarmellose sodium, calcium chloride, lactose are added in suitable quantity of water, heating makes completely molten Solution, obtains solution A, methyl hydroxybenzoate be dissolved in ethyl alcohol solution B is slowly added into solution A by solution B under agitation, after Continuous stirring, is added chitosan, and high speed shear 2 hours obtains mixed liquor C, is freeze-dried uniformly powdered deposited by mixed liquor C Material.
Embodiment 2
Croscarmellose sodium 35%, chitosan 30%, calcium chloride 1%, methyl hydroxybenzoate 2%, talcum powder 16%, breast Sugar 16%；
The preparation method is the same as that of Example 1.
Embodiment 3
Croscarmellose sodium 20%, chitosan 45%, calcium chloride 1%, methyl hydroxybenzoate 2%, talcum powder 16%, breast Sugar 16%；
The preparation method is the same as that of Example 1.
Embodiment 4
Croscarmellose sodium 15%, chitosan 50%, calcium chloride 1%, methyl hydroxybenzoate 2%, talcum powder 16%, breast Sugar 16%；
The preparation method is the same as that of Example 1.
Embodiment 5
Croscarmellose sodium 65%, calcium chloride 1%, methyl hydroxybenzoate 2%, talcum powder 16%, lactose 16%；
The preparation method is the same as that of Example 1.
Embodiment 6
Croscarmellose sodium 51%, chitosan 15%, methyl hydroxybenzoate 2%, talcum powder 16%, lactose 16%；
The preparation method is the same as that of Example 1.
The hemostasis of rats'liver Hemorrhage Model is tested
Rat is grouped at random, every group 6, respectively positive controls (He Xueting) and experimental group, the injection of each group rat 10% chloraldurate 1mL anesthesia, cuts abdominal muscle, squeezes out liver organ, blot liver surrounding liquid, the gauze after drop is weighed is padded on Under liver, the liver middle period is quickly cut off in each experimental group liver lower edge same location, uniformly smears equivalent positive drug and experimental drug Object is in incision, and timing to stopped bleeding, with the exudation of no bright red blood to stop bleeding standard, observation each group obtains blood clotting situation, Amount of bleeding and bleeding stopping period are recorded, amount of bleeding is in terms of gauze weightening, and the bleeding time, each group obtained to cut off the liver middle period to stopped bleeding Haemostatic effect is as follows：
According to above-mentioned experimental data it is found that the bleeding time of 1-3 each group compositions of the embodiment of the present invention and amount of bleeding and sun Property control group compare, all have more significant shortening and reduction, embodiment 4 has extended bleeding time and amount of bleeding, this may With the reduction of croscarmellose sodium dosage, absorption liquid ability is caused to decline related, and then powder is in the non-shape in wound At firm hemostasis gel, and the removal of chitosan and the removal of calcium chloride result in being remarkably decreased for hemostatic capability, show The two plays important hemostatic function in combination.

Claims (10)

1. a kind of bleeding-stopping dressing, which is characterized in that the dressing is powder composition, the polymerization containing water absorption and swelling in composition Object, promotees blood coagulation substance at fungicide.
2. bleeding-stopping dressing as described in claim 1, which is characterized in that the polymer of the water absorption and swelling is that cross-linked carboxymethyl is fine The plain sodium of dimension.
3. bleeding-stopping dressing as described in claim 1, which is characterized in that the fungicide is selected from chitosan.
4. bleeding-stopping dressing as described in claim 1, which is characterized in that the rush blood coagulation substance is selected from calcium chloride, fibrin One or more of original, vitamin K, collagen, fibronectin, coagulation factor combine.
5. bleeding-stopping dressing as described in claim 1, which is characterized in that further contain preservative, filler in composition.
6. bleeding-stopping dressing as claimed in claim 5, which is characterized in that the preservative is selected from methyl hydroxybenzoate, ethyl hydroxy benzoate, benzene One or more of sodium formate, dimethyl fumarate combine, filler be selected from talcum powder, starch, lactose, calcium carbonate, dextrin, One or more of microcrystalline cellulose combines.
7. a kind of bleeding-stopping dressing, which is characterized in that the dressing is powder composition, contains following components by weight percent object in composition Matter：20-50 parts of croscarmellose sodium, promotees 1 part of blood coagulation substance at 15-45 parts of fungicide.
8. bleeding-stopping dressing as claimed in claim 7, which is characterized in that contain following parts by weight of component object in the composition Matter：20-50 parts of croscarmellose sodium, promotees 1 part of blood coagulation substance, 2 parts of methyl hydroxybenzoate, talcum powder 16 at 15-45 parts of fungicide Part, 16 parts of lactose.
9. bleeding-stopping dressing as claimed in claim 7, which is characterized in that the dressing contains following parts by weight of component：It is crosslinked carboxylic 50 parts of sodium carboxymethylcellulose pyce, 15 parts of chitosan, 1 part of calcium chloride, 2 parts of methyl hydroxybenzoate, 16 parts of talcum powder, 16 parts of lactose.
10. a kind of preparation method of bleeding-stopping dressing as claimed in claim 8, which is characterized in that by cross-linked carboxymethyl cellulose Sodium, calcium chloride, lactose are added in suitable quantity of water, and heating makes to be completely dissolved, and obtain solution A, and methyl hydroxybenzoate, which is dissolved in ethyl alcohol, obtains solution B, Under agitation, solution B is slowly added into solution A, continues to stir, chitosan is added, high speed shear 2 hours obtains mixed Liquid C is closed, mixed liquor C is freeze-dried to obtain uniformly powdered dressing.
CN201810460000.8A 2018-05-15 2018-05-15 A kind of bleeding-stopping dressing Pending CN108478855A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810460000.8A CN108478855A (en) 2018-05-15 2018-05-15 A kind of bleeding-stopping dressing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810460000.8A CN108478855A (en) 2018-05-15 2018-05-15 A kind of bleeding-stopping dressing

Publications (1)

Publication Number Publication Date
CN108478855A true CN108478855A (en) 2018-09-04

Family

ID=63354431

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810460000.8A Pending CN108478855A (en) 2018-05-15 2018-05-15 A kind of bleeding-stopping dressing

Country Status (1)

Country Link
CN (1) CN108478855A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109125795A (en) * 2018-10-18 2019-01-04 赛克赛斯生物科技股份有限公司 A kind of polysaccharide hemostatic composition and the preparation method and application thereof
CN109395143A (en) * 2018-10-16 2019-03-01 广州润虹医药科技股份有限公司 A kind of antiseptic anti-adhesion hydrocolloid oil yarn and preparation method thereof
CN111840632A (en) * 2019-04-25 2020-10-30 广东泰宝医疗科技股份有限公司 Liquid dressing containing hemostatic microcapsule and preparation method thereof
CN115212349A (en) * 2022-07-05 2022-10-21 浦易(上海)生物技术股份有限公司 Gelable compositions, methods of preparation and uses thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102908652A (en) * 2012-11-07 2013-02-06 中国人民解放军第二军医大学 Composite hemostatic material mainly used for emergency aid
US20140099374A1 (en) * 2009-10-06 2014-04-10 Regents Of The University Of Minnesota Bioresorbable embolization microspheres
CN105920658A (en) * 2016-04-23 2016-09-07 厦门凝赋生物科技有限公司 Porous styptic powder and preparation method thereof
CN106178088A (en) * 2016-08-16 2016-12-07 江苏海泽医疗科技发展有限公司 A kind of preparation method of styptic powder
CN107243086A (en) * 2017-06-06 2017-10-13 广西达庆生物科技股份有限公司 A kind of absorbable compound hemostatic powder and preparation method thereof
CN107708751A (en) * 2015-06-26 2018-02-16 韩国生产技术研究院 Medical fibre structure comprising calcium carboxymethylcellulose and chitosan compound and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140099374A1 (en) * 2009-10-06 2014-04-10 Regents Of The University Of Minnesota Bioresorbable embolization microspheres
CN102908652A (en) * 2012-11-07 2013-02-06 中国人民解放军第二军医大学 Composite hemostatic material mainly used for emergency aid
CN107708751A (en) * 2015-06-26 2018-02-16 韩国生产技术研究院 Medical fibre structure comprising calcium carboxymethylcellulose and chitosan compound and preparation method thereof
CN105920658A (en) * 2016-04-23 2016-09-07 厦门凝赋生物科技有限公司 Porous styptic powder and preparation method thereof
CN106178088A (en) * 2016-08-16 2016-12-07 江苏海泽医疗科技发展有限公司 A kind of preparation method of styptic powder
CN107243086A (en) * 2017-06-06 2017-10-13 广西达庆生物科技股份有限公司 A kind of absorbable compound hemostatic powder and preparation method thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109395143A (en) * 2018-10-16 2019-03-01 广州润虹医药科技股份有限公司 A kind of antiseptic anti-adhesion hydrocolloid oil yarn and preparation method thereof
CN109395143B (en) * 2018-10-16 2021-06-01 广州润虹医药科技股份有限公司 Antibacterial anti-adhesion hydrocolloid oily yarn and preparation method thereof
CN109125795A (en) * 2018-10-18 2019-01-04 赛克赛斯生物科技股份有限公司 A kind of polysaccharide hemostatic composition and the preparation method and application thereof
CN109125795B (en) * 2018-10-18 2021-06-15 赛克赛斯生物科技股份有限公司 Polysaccharide hemostatic composition and preparation method and application thereof
CN111840632A (en) * 2019-04-25 2020-10-30 广东泰宝医疗科技股份有限公司 Liquid dressing containing hemostatic microcapsule and preparation method thereof
CN115212349A (en) * 2022-07-05 2022-10-21 浦易(上海)生物技术股份有限公司 Gelable compositions, methods of preparation and uses thereof
CN115212349B (en) * 2022-07-05 2023-11-21 浦易(上海)生物技术股份有限公司 Gellable composition, method for the production and use thereof

Similar Documents

Publication Publication Date Title
US20230381288A1 (en) Hemostatic compositions
JP6868314B2 (en) Wound dressing containing hyaluronic acid-calcium and polylysine and its manufacturing method
CN108478855A (en) A kind of bleeding-stopping dressing
Wan et al. Injectable adhesive self-healing biocompatible hydrogel for haemostasis, wound healing, and postoperative tissue adhesion prevention in nephron-sparing surgery
AU2017310470B2 (en) Hemostatic flowable
CN106474524A (en) A kind of degradable starch sthptic sponge and preparation method thereof
RU2731371C2 (en) Haemostatic mixture of short and long cellulose-based fibers
GB2447685A (en) Haemostatic and dentifrice compositions
CN105597142A (en) Medical bio-fiber styptic powder material and preparation method thereof
CN104491917B (en) A kind of biomaterial containing PEG or derivatives thereof
NZ750516B2 (en) Hemostatic flowable
CN105664233A (en) Novel hemostatic material and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180904